MR
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis | Haematologica |  | 2019 | 383 | 145 | ||
| Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy | Biology of Blood and Marrow Transplantation |  | 2019 | 299 | 0 | ||
| State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019 | Haematologica | | 2019 | 360 | 283 | ||
| Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | | 2019 | 284 | 0 | ||
| Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia | British Journal of Haematology | | 2019 | 309 | 0 | ||
| Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis | Haematologica | | 2019 | 317 | 239 | ||
| Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT | British Journal of Haematology | | 2018 | 423 | 0 | ||
| Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes | Biology of Blood and Marrow Transplantation | | 2016 | 310 | 207 |
